Inici › Diabetis tipus 1 › Washington › Seattle
Assaigs clínics de Diabetis tipus 1 a Seattle, WA
18 estudis de Diabetis tipus 1 busquen participants en centres de Seattle i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Type 1 Diabetes Extension Study
ReclutantEstudi observacional
- Benaroya Research Institute, Seattle
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
ReclutantFase 2
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
ReclutantFase 3
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
ReclutantFase 1/2
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
ReclutantFase 2
- Benaroya Research Institute, Seattle
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
ReclutantFase 2
- Benaroya Research Institute, Seattle
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
ReclutantFase 1/2
- Seattle Children's Hospital, Seattle
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
ReclutantFase 2
- Benaroya Research Institute at Virginia Mason, Seattle
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Reclutant
- University of Washington, Seattle
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
ReclutantFase 2
- University of Washington, Seattle
Kidney Precision Medicine Project
ReclutantEstudi observacional
- University of Washington, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
ReclutantFase 3
- University of Washington, Seattle
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
ReclutantFase 3
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
Reclutant
- Seattle Children's, Seattle
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
ReclutantEstudi observacional
- Benaroya Research Institute, Seattle
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Reclutant
- Seattle Children's, Seattle
TrialNet Pathway to Prevention of T1D
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Benaroya Research Institute, Seattle
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
ReclutantFase 1
- Seattle Children's Hospital, Seattle
Assaigs de Diabetis tipus 1 en altres ciutats
- Aurora, CO23 estudis
- Boston, MA21 estudis
- Chicago, IL16 estudis
- New Haven, CT15 estudis
- New York City, NY15 estudis
- Indianapolis, IN14 estudis
- San Francisco, CA14 estudis
- Miami, FL13 estudis
- Gainesville, FL12 estudis
- Philadelphia, PA11 estudis
- Atlanta, GA11 estudis
- Durham, NC10 estudis
Altres estudis a Seattle
- Càncer de pulmó de cèl·lules no petites53 estudis
- Càncer (tots els tipus)49 estudis
- Càncer de pròstata42 estudis
- Leucèmia mieloide aguda40 estudis
- Càncer de mama39 estudis
- Càncer metastàtic39 estudis
- Càncer colorrectal34 estudis
- Càncer de pulmó33 estudis
- Càncer d'ovari30 estudis
- Mieloma múltiple22 estudis
- Síndromes mielodisplàsiques21 estudis
- Leucèmia limfoblàstica aguda21 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.